oxazoles has been researched along with 2-(2,6-diisopropylphenyl)-5-hydroxy-1h-isoindole-1,3-dione in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, G; Komiya, M; Mutoh, M; Noma, N; Shimura, M; Takahashi, M; Tanuma, S; Yamamoto, M; Yanaka, A | 1 |
1 other study(ies) available for oxazoles and 2-(2,6-diisopropylphenyl)-5-hydroxy-1h-isoindole-1,3-dione
Article | Year |
---|---|
Novel compound SK-1009 suppresses interleukin-6 expression through modulation of activation of nuclear factor-kappaB pathway.
Topics: Anti-Inflammatory Agents; Cell Line, Tumor; Colonic Neoplasms; Humans; I-kappa B Proteins; Inflammation; Inflammation Mediators; Interleukin-6; Isoindoles; Macrophages; NF-kappa B; Oxazoles; RNA, Messenger; Signal Transduction | 2012 |